Please provide your email address to receive an email when new articles are posted on . Althera announced the FDA approved its rosuvastatin/ezetimibe tablets as an adjunct to diet for treatment of ...
- NEXLIZET Lowered LDL-C by 38 Percent Compared to Placebo when Added on to Maximally Tolerated Statins -- First Non-Statin, LDL-Cholesterol Lowering Combination Medicine Ever Approved -- Esperion’s ...
Please provide your email address to receive an email when new articles are posted on . A combination of obicetrapib and ezetimibe further lowered LDL in statin-treated patients with dyslipidemia. A ...
Results from the largest community-based clinical trial to date, involving more than 3000 patients, has shown that adding the cholesterol absorption inhibitor ezetimibe to ongoing stable statin ...
NEW ORLEANS, November 8, 2004 – Results from a new study showed that coadministration of ZETIA® (ezetimibe) and fenofibrate significantly reduced LDL ("bad") cholesterol (LDL-C), non-high density ...
Reduce elevated total-C and LDL-C in patients with homozygous familial; hypercholesterolemia (HoFH), in combination with atorvastatin or simvastatin; and Reduce elevated sitosterol and campesterol in ...
Obicetrapib, a Lazarus-like cholesteryl ester transfer protein (CETP) inhibitor currently on its second life, checked another box in its development program with investigators showing the drug could ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results